TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
IrenePharma Oy
Closing information (x1000 NOK)
Closing information | 2017/10 | 2016/10 | 2015/10 |
Turnover |
18,505
|
15,765
|
14,345 |
Financial expenses |
19
|
18
|
0 |
Earnings before taxes |
4,048
|
3,216
|
2,907 |
Total assets |
12,505
|
10,028
|
8,314 |
Current assets |
257
|
126
|
1,633 |
Current liabilities |
981
|
813
|
774 |
Equity capital |
11,533
|
9,215
|
7,540 |
- share capital |
29
|
27
|
28 |
Financial ratios
Fiscal year | 2017/10 | 2016/10 | 2015/10 |
Solvency |
92.2%
|
91.9%
|
90.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
21.9%
|
20.4%
|
20.3% |
Return on assets (ROA) |
32.5%
|
32.2%
|
35.0% |
Current ratio |
26.2%
|
15.5%
|
211.0% |
Return on equity (ROE) |
35.1%
|
34.9%
|
38.6% |
Change turnover |
1,886
|
2,033
|
349 |
Change turnover % |
11%
|
15%
|
2% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2017/10 | 2016/10 | 2015/10 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.